alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 4.2

 

	
Number
   A-
    	
 
    	
Incorporated Under the Laws of the State of Delaware
    	
 
    	
Shares
   -0-
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
Cusip No.
    


 

LIBERTY INTERACTIVE CORPORATION

 

Series B QVC Group Common Stock, par value $.01 per share

 

Specimen Certificate

 

This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF SERIES A QVC GROUP COMMON STOCK, PAR VALUE $0.01 PER SHARE, OF LIBERTY INTERACTIVE CORPORATION (hereinafter called the “Corporation”) transferable on the books of the Corporation by the holder hereof in person or by duly authorized attorney upon surrender of the Certificate properly endorsed. This Certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar.

 

Witness, the seal of the Corporation and the signatures of its duly authorized officers.

 

	
Dated:
    	
 
    
	
 
    	
 
    
	
 
    	
Liberty   Interactive Corporation
    
	
 
    	
 
    
	
 
    	
 
    
	
President
    	
Secretary
IN THE UNITED STATES DISTRICT COURT

FOR THE SOUTHERN DISTRICT OF ALABAMA

SOUTHERN DIVISION

FAMILY MEDICINE PHARMACY, 

LLC,

)

)

)

Plaintiff, )

)

vs. ) CIVIL ACTION NO. 15-0290-CG-N

)

OWEN MUMFORD USA, 

INCORPORATED,

)

)

)

Defendant. )

ORDER

The parties having filed a joint Stipulation of Dismissal with Prejudice (Doc. 

33), the Plaintiff’s claims against Defendant Owen Mumford USA, Incorporation are

hereby DISMISSED with prejudice; and all claims asserted on behalf of the 

putative class in this case are DISMISSED without prejudice. Each party shall 

bear its own costs.

DONE and ORDERED this 30th day of October 2015.

/s/ Callie V. S. Granade

UNITED STATES DISTRICT JUDGE

Case 1:15-cv-00290-CG-N Document 35 Filed 10/30/15 Page 1 of 1
Exhibit 11.1

                         CORCOM, INC. AND SUBSIDIARIES
                  COMPUTATION OF EARNINGS PER SHARE (UNAUDITED)
                      (In Thousands, except Per Share Data)


                         Thirteen Weeks Ended      Thirty-Nine Weeks Ended
                      --------------------------  --------------------------
                      September 28  September 30  September 28  September 30
                          1996          1995          1996          1995
                      ------------  ------------  ------------  ------------
Net earnings per
 common and common
 equivalent share:

Average shares
 outstanding                 3,795         3,716         3,778         3,670

Additional shares assuming 
exercise of dilutive stock
options based on the
treasury stock method using
average market price           190           207           191          167


AVERAGE NUMBER OF
COMMON AND COMMON
EQUIVALENT SHARES            3,985         3,923         3,969        3,837

Net earnings                $1,034          $753        $3,601       $2,000

Net earnings per common
and common equivalent
share                        $0.26         $0.19         $0.91        $0.52


Net earnings per common and
common equivalent share -
assuming full dilution:

Average shares outstanding   3,795         3,716         3,778        3,670

Additional shares assuming
exercise of dilutive stock
options based on the treasury
stock method using the period
end price if higher than the
average market price           197           215           196          214

FULLY DILUTED AVERAGE
NUMBER OF COMMON AND
COMMON EQUIVALENT SHARES     3,992         3,931         3,974        3,884

Net earnings                $1,034          $753        $3,601       $2,000

Net earnings per common
and common equivalent share  $0.26         $0.19         $0.91        $0.51
<PAGE> 17

                                 C.M. CORP.

                       INCOME (LOSS) PER COMMON SHARE
                 FOR THE CONDENSED STATEMENTS OF OPERATIONS

               (Dollars in Thousands, Except Per Share Data)



                              Three Months Ended        Nine Months Ended
                                 September 30,             September 30,
                           -------------------------   ------------------
                              1997         1996         1997        1996
                            ----------   ----------    -------   -------

Net income (loss)             $    (4)    $   (70)     $    17   $   (90)
                              =======     =======      =======   =======

Total common shares             1,000       1,000        1,000     1,000
                              =======     =======      =======   =======

Income (loss) per 
  common share                $    (4)    $   (70)     $    17   $   (90)
                              =======     =======      =======   =======
EXHIBIT 32.1

                               CERTIFICATION PURSUANT TO
                                 18 USC, SECTION 1350,
                                AS ADOPTED PURSUANT TO
                      SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the quarterly report of 3Si Holdings, Inc.
(the "Company") on Form 10-QSB for the three month period ended March
31, 2006, as filed with the Securities and Exchange Commission on
July 26, 2007 (the "Report"), I, the undersigned, in the capacity and
on the date indicated below, certify, pursuant to 18 U.S.C./ Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that to the best of my knowledge:

1.  The Report fully complies with the requirements of Rule 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

2.  The information contained in the Report fairly presents, in
all material respects, the financial condition and results of
operations of the Company.



Dated: July 26, 2007                   /s/  Frederick J. Slack
                                       Frederick J. Slack, Chief
                                       Executive Officer,
                                       Chief Financial Officer
#### The People of the State of New York ex rel. Farrington, Relator, *v.*Children’s Aid Society of Rochester, Respondent.

Supreme Court, Monroe County,

March 17, 1925.

Parent and child — custody of children — habeas corpus proceeding to inquire into welfare of relator’s children committed to institution by County Court of Monroe county — Supreme Court without power to eñect relief in premises — relator should take proceedings in equity or apply to County Court which has power to modify its decree pursuant to Laws of 1910, chap. 611, § 15.

In the absence of any question as to the jurisdiction and power of the County Court of Monroe county, which had committed relator’s children to an institution, the Supreme Court is without power in a habeas corpus proceeding to inquire into the question of the children’s welfare and the proceeding should be dismissed and the children remanded to the institution to which they were committed.

The relator should take proceedings in equity or apply to the County Court for the relief sought in this proceeding, since said court has power, pursuant to section 15 of chapter 611 of the Laws of 1910, to modify its decree which committed the children to the institution in question.

Habeas corpus proceeding to inquire into detention of relator’s children committed to institution.

*Florence*Farrington, for the relator.

*Arthur Rathjen,*for the respondent.

Rodenbeck, J.:

In this proceeding the court cannot inquire into the question of the children’s welfare, and there being no question as to the jurisdiction and power of the County Court of Monroe county which committed them to the defendant, they must be remanded. *(People ex rel. Sampson*v. *N. Y. C. Protectory,*93 App. Div. 196.) There is ample power in said County Court to modify its decree (Laws of 1910, chap. 611, § 15) and the relator should apply to that court for the relief sought in this proceeding or take proceedings in equity. *(Matter of Knowack,*158 N. Y. 482.) The relator seems to be able to provide a home for her children and while perhaps not so good as might be desired, or even so good as they now have, her rights should be respected, but she cannot get relief in this proceeding.

*905The cases of *People ex rel. Riesner*v. *N. Y. N. & C. Hospital*(230 N. Y. 119) and *Matter of Standish*(197 App. Div. 176) are not in conflict with these views.

Writ dismissed and children remanded.
IN THE UNITED STATES DISTRICT COURT FOR THE

SOUTHERN DISTRICT OF ALABAMA

SOUTHERN DIVISION

RAMON LOFTON, :

Plaintiff, :

vs. : CIVIL ACTION 09-0798-CB-C

SAM COCHRAN, et al., :

Defendants. :

ORDER

After due and proper consideration of all portions of this file deemed relevant to

the issues raised, and there having been no objections filed, the Report and

Recommendation of the Magistrate Judge made under 28 U.S.C. § 636(b)(1)(B) is

ADOPTED as the opinion of this Court. It is ORDERED that this action be and is hereby

dismissed without prejudice.

DONE this 17th day of March , 2010.

s/Charles R. Butler, Jr. 

SENIOR UNITED STATES DISTRICT JUDGE

Case 1:09-cv-00798-CB-C Document 9 Filed 03/17/10 Page 1 of 1
THE THIRTEENTH COURT OF APPEALS

13-22-00026-CV

ANDREGER TOLBERT

v.

BRYANT TOLBERT

On Appeal from the

264th District Court of Bell County, Texas

Trial Court Cause No. 301,274-D

JUDGMENT

THE THIRTEENTH COURT OF APPEALS, having considered this cause on 

appeal, concludes the appeal should be dismissed. The Court orders the appeal 

DISMISSED in accordance with its opinion. No costs are assessed as appellant filed an 

affidavit of inability to pay costs.

We further order this decision certified below for observance.

May 26, 2022
Amendment Hahn Offer Letter













May 27, 2015


Marina Hahn
1155 Park Avenue  
New York, NY 10128  
Dear Marina:
Reference is made herein to that certain offer letter between you and Flex Pharma, Inc. (the “Company”) dated September 4, 2014 (the “Offer Letter”) and that certain Stock Option Grant Notice and Agreement dated November 10, 2014 (the “Option Agreement”). 
You acknowledge and agree that in accordance with the Offer Letter you were granted an option to purchase 248,855 shares of Common Stock of the Company (the “Option”) pursuant to the Option Agreement. The Offer Letter hereby is amended to provide that if within thirty (30) days prior to a Change in Control (as defined in the Offer Letter) or within twelve (12) months following a Change in Control, the Company or any successor thereto terminates your employment other than for Cause (as defined in the Offer Letter), or you terminate your employment for Good Reason (as defined in the Offer Letter), then the Company shall provide that all outstanding unvested equity awards granted to you (including but not limited to the Option) shall become fully vested as of the date of such termination.
In addition, if the Company (or any successor thereto) terminates your employment without Cause or you resign for Good Reason and you timely elect and remain eligible for continued coverage under COBRA, the Company will pay, for a period of nine months following such termination of employment, a percentage of your COBRA premiums that is equal to the percentage of your insurance premiums that the Company was paying prior to date of termination.
All other terms and provisions of the Offer Letter and the Option Agreement not expressly modified hereby shall remain in full force and effect.  This letter may not be modified or amended except by a written agreement signed by the Company and you.





 










  
                 Sincerely, 
 
                               Flex Pharma, Inc.         
/s/ John McCabe    
Name: John McCabe 
Title: Vice President, Finance
Agreed to and accepted: 

/s/ Marina Hahn    
Marina Hahn
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1808 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
                                H. R. 1808

 To amend title 10, United States Code, to prohibit discrimination in 
                           the Armed Forces.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 27, 2023

    Ms. Jacobs (for herself, Mr. Grijalva, Ms. Norton, Ms. Moore of 
  Wisconsin, Mr. Takano, Ms. Schakowsky, Ms. Sanchez, Mr. Johnson of 
Georgia, Mr. Nadler, Mr. Blumenauer, Mr. Pocan, Mr. Payne, Ms. Escobar, 
Mr. Krishnamoorthi, Mr. Cicilline, Ms. Garcia of Texas, Ms. Tokuda, Mr. 
 Veasey, Ms. Bonamici, Mr. McGovern, Mrs. Watson Coleman, Mr. Sherman, 
and Ms. Velazquez) introduced the following bill; which was referred to 
                    the Committee on Armed Services

_______________________________________________________________________

                                 A BILL

 
 To amend title 10, United States Code, to prohibit discrimination in 
                           the Armed Forces.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ensuring Military Readiness Not 
Discrimination Act''.

SEC. 2. NONDISCRIMINATION WITH RESPECT TO SERVICE IN THE ARMED FORCES.

    (a) In General.--Chapter 37 of title 10, United States Code, is 
amended by inserting after section 651 the following new section:
``Sec. 651a. Members: prohibition of gender discrimination
    ``(a) Standards for Eligibility for Service.--Any qualifications 
established or applied for eligibility for service in an Armed Force 
shall take into account only the ability of an individual to meet 
occupational standards for military service generally and the military 
occupational specialty concerned in particular, and may not include any 
criteria relating to the race, color, national origin, religion, or sex 
(including gender identity, sexual orientation, or sex characteristics 
(including intersex traits)) of an individual.
    ``(b) Equality of Treatment and Opportunity in Service.--Any 
personnel policy developed or implemented by the Secretary concerned 
with respect to members of the Armed Forces shall ensure equality of 
treatment and opportunity for all persons in the Armed Forces, without 
regard to race, color, national origin, religion, and sex (including 
gender identity, sexual orientation, or sex characteristics (including 
intersex traits)).''.
    (b) Clerical Amendment.--The table of sections at the beginning of 
such chapter is amended by inserting after the item relating to section 
651 the following new item:

``651a. Members: prohibition of gender discrimination.''.
                                 <all>
```
I 

118TH CONGRESS 

1ST SESSION H. R. 2001 

To provide for a limitation on availability of funds for Department of Health 

and Human Services, National Institutes of Health Innovation Account, 

CURES Act for fiscal year 2024. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 29, 2023 

Mr. BIGGS (for himself, Mr. ROSENDALE, Mr. GAETZ, Mr. GOOD of Virginia, 

Mr. ROY, and Mr. CRANE) introduced the following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health Innovation Account, CURES Act for 

fiscal year 2024. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 2001 IH

1 SECTION 1. LIMITATION ON AVAILABILITY OF FUNDS FOR 

2 DEPARTMENT OF HEALTH AND HUMAN SERV3 ICES, NATIONAL INSTITUTES OF HEALTH IN4 NOVATION ACCOUNT, CURES ACT FOR FIS5 CAL YEAR 2024. 

6 Notwithstanding any other provision of the law, 

7 amounts authorized to be appropriated or otherwise avail8 able for Department of Health and Human Services, Na9 tional Institutes of Health Innovation Account, CURES 

10 Act for fiscal year 2024 may not exceed $496,000,000. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   YEAR                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998             DEC-31-1999
<PERIOD-START>                             JAN-01-1998             JAN-01-1999
<PERIOD-END>                               DEC-31-1998             DEC-31-1999
<CASH>                                         374,567              78,052,259
<SECURITIES>                                         0               9,912,500
<RECEIVABLES>                                1,065,864              11,234,321
<ALLOWANCES>                                   129,367               3,604,693
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                             1,311,064              96,534,326
<PP&E>                                         166,705               4,482,490
<DEPRECIATION>                                  60,784                 443,031
<TOTAL-ASSETS>                               1,444,015             103,442,487
<CURRENT-LIABILITIES>                        3,173,600              12,449,069
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                           698                   3,169
<OTHER-SE>                                   1,482,685             134,324,423
<TOTAL-LIABILITY-AND-EQUITY>                 1,444,015             103,442,487
<SALES>                                      3,588,094              26,405,120
<TOTAL-REVENUES>                             3,588,094              26,405,120
<CGS>                                        2,770,567              20,417,637
<TOTAL-COSTS>                                2,770,567              20,417,637
<OTHER-EXPENSES>                             2,589,553              28,714,299
<LOSS-PROVISION>                            (1,772,026)            (22,726,816)
<INTEREST-EXPENSE>                             247,186               (912,289)
<INCOME-PRETAX>                             (2,019,212)            (21,814,527)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                         (2,019,212)            (21,814,527)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                (2,019,212)            (21,814,527)
<EPS-BASIC>                                      (0.25)                  (2.34)
<EPS-DILUTED>                                    (0.25)                  (2.34)



</TABLE>
#### Laurent Adamowicz, Appellant, v Pierre Besnainou et al., Defendants, and Fauchon, Inc. (US), et al., Respondents.

[872 NYS2d 47]

Order, Supreme Court, New York County (Richard B. Lowe, III, J.), entered May 10, 2007, which granted the motion of defendants Fauchon Holding, SAS, Fauchon SAS, Groupe Fauchon, S.A., and Waldo S.A. to dismiss the complaint as against them for lack of personal jurisdiction and on the ground of forum non conveniens, and granted the motion to dismiss the complaint as against defendant Fauchon, Inc. (US) on the ground of forum non conveniens on condition that defendants make themselves amenable to service of process in France and waive any statute of limitations defenses, unanimously affirmed, with costs.

While reflecting the occasional visit to New York by representatives of some of the foreign corporate defendants, the record does not show that “the corporation[s] [are] present in the State not occasionally or casually, but with a fair measure of permanence and continuity,” and therefore are subject to in personam jurisdiction in this State *(see Landoil Resources Corp. v Alexander & Alexander Servs.,*77 NY2d 28, 34 [1990] [internal quotation marks and citation omitted]).

In any event, the complaint was properly dismissed on the *547ground of forum non conveniens *(see Islamic Republic of Iran v Pahlavi,*62 NY2d 474, 482 [1984], *cert denied*469 US 1108 [1985]; *Kuwaiti Eng’g Group v Consortium of Intl. Consultants, LLC,*50 AD3d 599 [2008]; *and see Adamowicz v Barclays Private Equity France S.A.S.,*2006 WL 728394, 2006 US Dist LEXIS 11675 [SD NY 2006]). While one of the corporate defendants (Fauchon US) is present in New York, and plaintiff, a permanent resident of the United States, may have been in the United States when he engaged in certain negotiations with defendant Besnainou, all the corporate and individual defendants other than Fauchon US, plus the minority investors, are located in France or other European countries. Plaintiff has failed to identify a single witness other than himself who might be present in this country. The loan agreement alleged to have been breached was written in French, was executed in France, was to be performed in France, and was allegedly breached in France. Plaintiff allegedly was compelled to sell his shares in the defendant corporations as a result of the choices presented to him by a French receiver acting under French law, and all the relevant documentary evidence is located in France or in other European countries. Concur—Saxe, J.E, Gonzalez, Sweeny, Renwick and DeGrasse, JJ.
Michigan Supreme Court

Lansing, Michigan

Marilyn Kelly,

 Chief Justice

Michael F. Cavanagh

Elizabeth A. Weaver

Maura D. Corrigan

Robert P. Young, Jr.

Stephen J. Markman

Diane M. Hathaway, Justices

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

 _________________________________________ 

 Clerk

November 13, 2009 

s1110 

Order 

 

November 13, 2009 

138976 

ANN COBLENTZ, LEE COBLENTZ, JOHN 

LEWANDOWSKI, and DEBORAH 

LEWANDOWSKI, 

Plaintiffs-Appellants, 

v SC: 138976 

 COA: 290075 

Oakland CC: 03-046760-CZ 

CITY OF NOVI, 

Defendant-Appellee. 

_________________________________________/ 

 On order of the Court, the application for leave to appeal the May 8, 2009 order of 

the Court of Appeals is considered, and it is DENIED, because we are not persuaded that 

the question presented should be reviewed by this Court.
#### The People of the State of New York, Respondent, v Mauricio Corona, Appellant.

[971 NYS2d 209]

— Appeal by the defendant, as limited by his motion, from a sentence of the Supreme Court, Queens County (Camacho, J.), imposed September 9, 2010, on the ground that the sentence was excessive.

Ordered that the sentence is affirmed.

The sentence imposed was not excessive *(see People v Suitte,*90 AD2d 80 [1982]). Eng, EJ., Skelos, Roman, Cohen and Hinds-Radix, JJ., concur.
I 

118TH CONGRESS 

1ST SESSION H. R. 2094 

To provide for a limitation on availability of funds for District of Columbia, 

Federal Payment for the DC Courts, DC Court System for fiscal year 2024. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 29, 2023 

Mr. BIGGS (for himself, Mr. ROSENDALE, Mr. GAETZ, Mr. GOOD of Virginia, 

Mr. ROY, and Mr. CRANE) introduced the following bill; which was referred to the Committee on Oversight and Accountability 

A BILL 

To provide for a limitation on availability of funds for District of Columbia, Federal Payment for the DC Courts, 

DC Court System for fiscal year 2024. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. LIMITATION ON AVAILABILITY OF FUNDS FOR 

4 DISTRICT OF COLUMBIA, FEDERAL PAYMENT 

5 FOR THE DC COURTS, DC COURT SYSTEM 

6 FOR FISCAL YEAR 2024. 

7 Notwithstanding any other provision of the law, 

8 amounts authorized to be appropriated or otherwise avail9 able for District of Columbia, Federal Payment for the 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•HR 2094 IH

1 DC Courts, DC Court System for fiscal year 2024 may 

2 not exceed $74,400,000. 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB